Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
AllPet Inc. is managing its intellectual property within the Biotechnology & Pharmaceuticals technology area. The company's current prosecution activity is centered on 1 pending office action, which suggests a highly targeted approach to its patent filings. This action is assigned to 1 distinct examiner, simplifying the interaction between the applicant and the USPTO. Having only 1 active matter allows the company to dedicate its resources to resolving the specific legal and technical issues raised by this individual examiner.
The examination is occurring within 1 distinct art unit, which means the technical review is confined to a specific expertise group. NGUYEN, NGOC-ANH THI is the busiest examiner for the company, with 1 busiest examiner pending action. For a patent practitioner, this profile indicates that the immediate priority is to successfully navigate the review of this 1 examiner within the biotechnology sector. The goal is to provide a response that meets the technical expectations of the art unit while addressing the specific feedback from the busiest examiner to secure the desired patent protection.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, NGOC-ANH THI | 1 | 30.3% | +50.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18656476 | Activated Carbon for Detoxification of Intoxications, Including Methods of Use Thereof | NGUYEN, NGOC-ANH THI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18656476 | Activated Carbon for Detoxification of Intoxications, Including Methods of Use Thereof | NGUYEN, NGOC-ANH THI | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18656476 | Activated Carbon for Detoxification of Intoxications, Including Methods of Use Thereof | NGUYEN, NGOC-ANH THI | 1615 | §102§112 | Non-Final OA | — | Pending | May 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAllPet Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ngoc-Anh Thi Nguyen has the most, with 1 of AllPet Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
